Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
5 Patents
#5 in Woodside, CA
#12,079 in California
#51,669 in US
Manzanita Pharmaceuticals, Inc.
Forward Citations = 28
4 inventors:
Woodside, CA, United States of America
Manzanita Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 80.0
EPO Patents = 1
Forward Citations = 28
Loading Chart...
Loading Chart...
4 inventors (with patents filed for the assignee):
Constance A McKee (5 out of 7 patents)
Robert R Webb (4 out of 7 patents)
Stephen B Kahl (2 out of 6 patents)
4. G Craig Hill (1 out of 1 patent)
5 patents:
2. 8232251 - Compounds for delivery of therapeutic and imaging moieties to nerve cells (2012-07-31),
3. 8138155 - Compounds for intracellular delivery of therapeutic moieties to nerve cells (2012-03-20),
Company Overview
Manzanita Pharmaceuticals, Inc. is a cutting-edge biopharmaceutical company focused on developing innovative treatments for a variety of medical conditions. Our team of researchers and scientists are dedicated to advancing the field of medicine and improving patient outcomes. With a strong pipeline of potential therapies, we are committed to making a positive impact on healthcare worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Manzanita Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/manzanita-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]